LANNETT SHARES UPDATE | MarketScreener
Announces Positive Results from Pivotal Clinical Insulin Trial that Demonstrates Biosimilarity to Reference Product Productive Conversations with Key Secured Creditors Toward a Balance Sheet... | April 4, 2023
Source: marketscreener.com